109
Participants
Start Date
March 23, 2020
Primary Completion Date
July 23, 2020
Study Completion Date
September 30, 2024
Blood draw
8x9mL EDTA tubes. In subjects treated with hydroxychloroquine treatment an extra EDTA tube (4mL) will be collected for the REVIVE substudy.
Bronchoalveolar lavage
Only in case of diagnostic or therapeutic indication.
SARS CoV-2 swabs
Nasopharyngeal, oropharyngeal and nasal swabs
AZ Jan Palfijn, Ghent
AZ Maria Middelares, Ghent
UZ Gent, Ghent
Collaborators (1)
Fund for Scientific Research, Flanders, Belgium
OTHER
Chan Zuckerberg Initiative
OTHER
Flanders Institute for Biotechnology
UNKNOWN
University Hospital, Ghent
OTHER